Cargando…

Genome-wide association study stratified by MAPT haplotypes identifies potential novel loci in Parkinson’s disease

OBJECTIVE: To identify genetic factors that may modify the effects of the MAPT locus in Parkinson’s disease (PD). METHODS: We used data from the International Parkinson’s Disease Genomics Consortium (IPDGC) and the UK biobank (UKBB). We stratified the IPDGC cohort for carriers of the H1/H1 genotype...

Descripción completa

Detalles Bibliográficos
Autores principales:	Senkevich, Konstantin, Bandres-Ciga, Sara, Cisterna-García, Alejandro, Yu, Eric, Bustos, Bernabe I., Krohn, Lynne, Lubbe, Steven J., Botía, Juan A., Gan-Or, Ziv
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246147/ https://www.ncbi.nlm.nih.gov/pubmed/37292720 http://dx.doi.org/10.1101/2023.04.14.23288478

Ejemplares similares

Type 2 Diabetes as a Determinant of Parkinson’s Disease Risk and Progression
por: Chohan, Harneek, et al.
Publicado: (2021)

MAPT haplotype–stratified GWAS reveals differential association for AD risk variants
por: Strickland, Samantha L., et al.
Publicado: (2020)

Heritability Enrichment Implicates Microglia in Parkinson’s Disease Pathogenesis
por: Andersen, Maren Stolp, et al.
Publicado: (2021)

MAPT allele and haplotype frequencies in Nigerian Africans: population distribution and association with Parkinson’s disease risk and age at onset
por: Okunoye, Olaitan, et al.
Publicado: (2023)

Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue
por: Tauber, Christina V., et al.
Publicado: (2023)

Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels
por: Allen, Mariet, et al.
Publicado: (2014)

Black and African American Connections to Parkinson's Disease Study: Addressing Missing Diversity in Parkinson's Disease Genetics
por: Bandres‐Ciga, Sara
Publicado: (2022)

Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals
por: Winder-Rhodes, Sophie E., et al.
Publicado: (2015)

Navigating the ALS Genetic Labyrinth: The Role of MAPT Haplotypes
por: Tourtourikov, Ivan, et al.
Publicado: (2023)

The Role of MAPT Haplotype H2 and Isoform 1N/4R in Parkinsonism of Older Adults
por: Valenca, Guilherme T., et al.
Publicado: (2016)

Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease
por: Refenes, Nikolaos, et al.
Publicado: (2009)

Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland
por: Kaivorinne, Anna-Lotta, et al.
Publicado: (2008)

Genetics of NLRP3 suggests lack of involvement and inefficient druggability in Parkinson’s disease
por: Senkevich, Konstantin, et al.
Publicado: (2023)

Mapping the Diverse and Inclusive Future of Parkinson’s Disease Genetics and Its Widespread Impact
por: Elsayed, Inas, et al.
Publicado: (2021)

The Genetic Landscape of Parkinsonism-Related Dystonias and Atypical Parkinsonism-Related Syndromes
por: Diez-Fairen, Monica, et al.
Publicado: (2021)

Haplotype-based association analysis of the MAPT locus in Late Onset Alzheimer's disease
por: Mukherjee, Odity, et al.
Publicado: (2007)

Transcript Variants of Genes Involved in Neurodegeneration Are Differentially Regulated by the APOE and MAPT Haplotypes
por: Koks, Sulev, et al.
Publicado: (2021)

Effect Modification between Genes and Environment and Parkinson's Disease Risk
por: Periñán, Maria Teresa, et al.
Publicado: (2022)

Immunogenetic Determinants of Parkinson’s Disease Etiology
por: Kung, Pin-Jui, et al.
Publicado: (2022)

Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
por: Billingsley, Kimberley J., et al.
Publicado: (2019)

Genetic Architecture of MAPT Gene Region in Parkinson Disease Subtypes
por: Pascale, Esterina, et al.
Publicado: (2016)

Association of MAPT subhaplotypes with clinical and demographic features in Parkinson’s disease
por: Deutschlander, Angela B., et al.
Publicado: (2020)

APOE and MAPT Are Associated With Dementia in Neuropathologically Confirmed Parkinson's Disease
por: Tunold, Jon-Anders, et al.
Publicado: (2021)

Semantic Recollection in Parkinson’s Disease: Functional Reconfiguration and MAPT Variants
por: Harrington, Deborah L., et al.
Publicado: (2021)

Role of the Long Non-Coding RNA MAPT-AS1 in Regulation of Microtubule Associated Protein Tau (MAPT) Expression in Parkinson's Disease
por: Coupland, Kirsten G., et al.
Publicado: (2016)

Bidirectional relationship between olfaction and Parkinson’s disease
por: Kim, Jonggeol J., et al.
Publicado: (2023)

17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
por: Bowles, Kathryn R., et al.
Publicado: (2022)

Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson’s disease at 16q11.2 and MAPT H1 loci
por: Soutar, Marc P M, et al.
Publicado: (2022)

RIC3 variants are not associated with Parkinson’s disease in large European, Latin American, or East Asian cohorts
por: Brolin, Kajsa, et al.
Publicado: (2022)

Advancing Personalized Medicine in Common Forms of Parkinson’s Disease through Genetics: Current Therapeutics and the Future of Individualized Management
por: Reed, Xylena, et al.
Publicado: (2021)

Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders
por: Lai, Mang Ching, et al.
Publicado: (2017)

Cognitive Performance as a Function of MAPT Haplotype: A Prospective Longitudinal Study of an Essential Tremor Cohort
por: Ghanem, Ali, et al.
Publicado: (2023)

Fine mapping of the HLA locus in Parkinson’s disease in Europeans
por: Yu, Eric, et al.
Publicado: (2021)

Genetic overlap between Alzheimer’s disease and Parkinson’s disease at the MAPT locus
por: Desikan, Rahul S., et al.
Publicado: (2015)

Evaluating Lipid‐Lowering Drug Targets for Parkinson's Disease Prevention with Mendelian Randomization
por: Williams, Dylan M., et al.
Publicado: (2020)

MIDN locus structural variants and Parkinson's Disease risk
por: Billingsley, Kimberley J., et al.
Publicado: (2020)

Creating the Pick’s disease International Consortium: Association study of MAPT H2 haplotype with risk of Pick’s disease
por: Valentino, Rebecca R, et al.
Publicado: (2023)

The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers
por: Sánchez-Juan, Pascual, et al.
Publicado: (2019)

SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population
por: Trotta, Luca, et al.
Publicado: (2012)

SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians
por: Huang, Yue, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_a3e5q7jcvij1r7t8s86rma6kh5